Our results demonstrated that while ESCO2 overexpression showed no significant effect on apoptosis, its knockdown markedly increased apoptotic rates in breast cancer cells - consistent with previous observations in gastric and hypopharyngeal carcinomas (11, 24). Here, ESCO2 is linked to hypopharyngeal carcinoma.